Welcome to our searchable resource and literature collection on safer supply and related topics.
Found a broken link? Links do move around, so if you find one here that's broken, please let us know through the Contact form.
Resources
Guidelines | 2022
Clinical guidance, About prescribers
Commentary | 2022
Decriminalization/legalization, Hallucinogens/psychedelics, Policy/Regulatory
We examined measures of drug enforcement as predictors of next-year fatal overdose rates in the Washington/Baltimore High Intensity Drug Trafficking Area (W/B HIDTA).
Original research | 2022
Legal system/law enforcement, Overdose, Mortality, Outcomes, Illegal drugs
This paper explores the narratives of service users of contemporary methadone maintenance treatment services (MMT) in the Republic of Ireland to obtain their perspectives in the context of them neg
Original research | 2022
Substitution/OAT, About PWUD, Barriers and enablers
To investigate whether low barrier MOUD improved retention in care compared to traditional treatment.
Original research | 2022
Barriers and enablers, About PWUD, Substitution/OAT
We test a conceptual model that emphasizes indirect, mediated effects among key factors related to HIV testing in substance use disorder treatment organizations (SUTs), a critical evidence-based pr
Original research | 2022
Evidence base, Wrap-around services
Page Web | 2022
la politique / le cadre de réglementation
This study aimed to determine the feasibility and safety of a tapering dose of lisdexamfetamine for the treatment of acute methamphetamine (MA) withdrawal.
Original research | 2022
Stimulants, Withdrawal, Clinical guidance
We explored whether patients with benzodiazepine exposure at treatment entry would have similar 12-month retention compared to those without benzodiazepine exposure.
Original research | 2022
Substitution/OAT, Clinical guidance
The therapeutic benefits of cannabinoids remain unclear, especially when weighted against their adverse effects.
Lit review | 2022
Withdrawal, Clinical guidance
This study sought to characterize the gap in OAT treatment using a cascade of care framework, and determine factors associated with engagement and retention in treatment.
Original research | 2022
About PWUD, Substitution/OAT, Sex/Gender , Mental health, Rural/remote, Outcomes
This review of clinical research reports the evidence regarding biomedical and behavioral treatments for psychostimulant withdrawal symptoms.
Lit review | 2022
Withdrawal, Stimulants, Clinical guidance
This study sought to characterize the prevalence and correlates of having difficulty accessing SCS during the COVID-19 pandemic among people who use drugs in Vancouver, Canada.
Original research | 2022
SCS/OPS, About PWUD, Equity, Barriers and enablers
To explore the similarities and differences of organization-based and informal spotting (remote supervision of substance use) from the perspectives of spotters and spottees across Canada.
Original research | 2023
Harm reduction, Digital health, About PWUD
We investigated whether depiction of the characteristics of decedents represented in news articles about drug related deaths (DRD) was associated with differences in stigmatising attitudes and supp
Original research | 2023
Harm reduction, Stigma, Mortality
Drawing on qualitative interviews and ethnographic fieldwork with actors engaged in an Australian illicit drug policy reform campaign, this paper examines how particular modes of personal connectio
Original research | 2022
Policy/Regulatory, Advocacy, Equity
This study examines public attitudes towards the punishment of medical cannabis (MC) diversion in Israel.
Original research | 2022
Diversion
This observational prospective study aimed to determine whether duration to the earning of privileges of “take-home” methadone doses (as a part of behavioral enforcement) reflects long-term outcome
Original research | 2011
Carries/take-home doses, About PWUD, Substitution/OAT, Outcomes
